Replies to post #197579 on Biotech Values

[DewDiligence]

If AGN would 'have' to divest…Enox program, and I see no reason why…

The why is that AGN’s not divesting would result in TEVA’s owning AGN’s Lovenox rights as well as TEVA’s own version of generic Lovenox, which is clearly anticompetitive.